The largest database of trusted experimental protocols

8 protocols using cd8 pacific orange

1

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
FACS staining was performed in 96-well plates. After FcR-blocking with CD16/32 antibody (24G2, BioXcell) cells were incubated for 30min at 4°C with H-2Kd/M282-90 or H-2Db/E749-57 tetramers (NIH Tetramer facility) with the following antibodies: CD8-Pacific Orange (5H10, Life Technologies), CD3-Pacific Blue (17A2, BioLegend), CD4-APC/Cy7 (RM4-5, BioLegend), CD127-PE (SB/199, BioLegend), CD62L-FITC (MEL-14, BioLegend), CD103-PERCP/Cy5.5 (1E7, BioLegend) and CD69-PE/Cy7 (H1.2F3, BioLegend) or CXCR3-PE/Cy7 (CXCR3-173, BioLegend).
+ Open protocol
+ Expand
2

Multiparameter Flow Cytometry Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocytes and myeloid cells were prepared as above. Cells were stained according to standard protocols with combinations of the following anti-mouse antibodies: OX40-APC (eBioscience; clone, OX86), CD4-FITC (eBioscience; clone, GK1.5), CD4-APC-Cy7 (BD Biosciences; clone, GK1.5), CD8–Pacific Orange (Life Technologies; clone, 5H10), CD8–Pacific Blue (BD Biosciences; clone, 53-6.7), TCRb–Pacific Blue (BD Biosciences; clone, H57-597), TCRb-PE (BD Biosciences; clone, H57-597), NK1.1-PE-Cy7 (eBioscience; clone, PK136), CD19–Alexa Fluor 700 (eBioscience; clone, ebio1D3), CD19-APCCy7 (BD Biosciences; clone, 1D3), CXCR5-biotin (BD Biosciences; clone, 2G8), OX40L-PE (eBioscience; clone, RM134L), F4/80-PE-Cy7 (eBioscience; clone, BM8), CD11b-PerCP-Cy5.5 (BD Biosciences; clone, M1/70), CD11c-APC (eBiosciences; clone, N418), major histocompatibility complex II–efluor 450(I-A/I-E) (eBioscience; clone, M5/114.15.2), Ly6g-PerCP-Cy5.5 (BD Biosciences; clone, 1A8), and Ly6c-AF700 (BD Biosciences, clone: AL-21). When applicable for biotinylated antibodies, cells were stained with secondary QDot 605–conjugated streptavidin (Life Technologies). Cells were analyzed using an LSR II flow cytometer (BD Biosciences) and FlowJo software (TreeStar) or sorted on an Aria III (BD Biosciences).
+ Open protocol
+ Expand
3

Evaluating Peptide-Pulsed DC and Trastuzumab Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the ability of peptide-pulsed DCs plus trastuzumab to induce functional antigen-specific T cells, we measured ex vivo antigen-specific T cell activity against peptide-pulsed and tumor targets by tetramer staining and intracellular cytokine assays using peripheral blood mononuclear cells (PMBCs) isolated from the bloodstream 7 days ± 1 day post therapy. Peripheral blood mononuclear cells (PBMCs) were stained with CD8-Pacific Orange (MHCD0830; Life Technologies) along with PE-HLA-A*02:01 tetramers generated with E75 peptide, E90 peptide, or a negative control peptide, all from Beckman Coulter. For single-cell sorting, sort gates were determined by setting the CD8+ Tetramer+ gate so that it included no cells in the negative tetramer sample. Tetramer+CD8+ T cells were sorted by an iCyt Reflection high-speed sorter at 1 cell/well into a 96-well PCR plate with each well containing 4 μL buffer (0.5× PBS, 10 mM DTT, and 8 U RNaseOUT (Invitrogen). Plates were kept frozen at −80°C prior to RT-PCR analysis(63 (link)).
+ Open protocol
+ Expand
4

Cytokine Profiling of T Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heparinized whole blood (100 μl) was cultured in 96 U bottom culture plate and incubated with PMA/Ionomycin (10 ng/ml and 100 µg/ml, Sigma-Aldrich, UK), P. falciparum 3D7 schizonts lysate (5 µg/ml) and mycobacterium purified protein derivative (10 µg/ml, Statens Serum Institut, Denmark) in parallel with a non-stimulated background control for 24 h. Harvested cells were stained with surface markersCD3-APC-H7, CD4-PerCP (all from BD Biosciences, San Jose, CA, USA), and CD8-Pacific Orange (Invitrogen™ Life technologies, Carlsbad, CA, USA) and lysed as above. The cells were the permeabilized with 500 μl of 1× BD Cytofix/Cytoperm (BD Cytofix/Cytoperm™, San Diego, California) and then stained with intracellular markers IFN-γ-FITC (BD FastImmune™, San Jose, CA, USA) and TNF-PE (BD Biosciences, San Jose, California) for 30 min. The cells were then acquired as above and minimum of 10,000 CD4+ T cell events were collected per sample. Single stained BD comp beads were processed and acquired in parallel to samples each day and used for compensation. Analysis was conducted using FlowJo software version 9.7.5 (Tree Star Inc., San Carlos, CA, USA).
+ Open protocol
+ Expand
5

T Cell Subset Analysis in PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cell analyses were performed in purified peripheral blood mononuclear cells (PBMCs). A primary stain with unlabelled murine anti-human antibodies directed against PD-1 (clone EH12.2H7) or isotype control followed with secondary phycoerythrin (PE)-labelled goat-anti-mouse immunoglobulin antibody (Dako, Glostrup, Denmark) was followed by primary labelled surface stains as follows: CD4 (Pacific Blue); CD5 (allophycocyanin (APC)-AlexaFluor 700); CD25 (fluorescein isothiocyanate, FITC); CD45RA (energy-coupled dye, ECD or FITC); CD62L (PE or phycoerythrin-cyanin 5, PC5); CD127 (PE) (all from Beckman Coulter, CA, USA); CD8 (Pacific Orange) (Invitrogen, MD, USA); CD183 (APC) and CD194 (phycoerythrin-cyanin 7, PC7) (all from BD Biosciences, CA, USA). Analyses were done on a Gallios flow cytometer and T cell subsets were defined as follows: naïve (CD62L+CD45RA+), central memory (CM, CD62L−CD45RA+), effector memory (EM, CD62L−CD45RA−), TEMRA (CD62L+CD45RA−), TH1 (CD183+CD194−), TH2 (CD183−CD194+) and Treg (CD25+CD127−). Statistical analyses were performed using unpaired t tests for all subgroup results. A simple Bonferroni correction was applied to adjust for multiple testing, leading to a necessary p value of < 0.0025 for the definition of significance.
+ Open protocol
+ Expand
6

Multiparameter Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following monoclonal antibodies and cell dyes were used: CD45.1 FITC, CD45.2 AlexaFluor700, CD45.2 FITC, TCR-beta APC, CD4 PerCP-eFluor710, CD44 APC-eFluor780, CD25 PE-Cy7, L-selectin eFluor450, CD122 biotin (all eBioscience); CD8 Pacific Orange, streptavidin PE-TexasRed, LIVE/DEAD blue (all Invitrogen); and CD45.1 Brilliant Violet 650, CD4 Brilliant Violet 711, and TCR-beta PerCP-Cy5.5 (all BioLegend). Samples were acquired on LSR-II, LSRFortessa, or Fortessa X20 flow cytometers (BD), and analysis was performed with FlowJo software (Treestar).
+ Open protocol
+ Expand
7

Phenotypic Analysis of Murine Splenocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
For phenotypic analysis, animals were sacrificed at 24hrs utilizing CO2 euthanasia and their spleens were harvested. The spleens were processed into single-cell suspensions and the number of cells per mL of suspension was obtained via a Nexcelom Auto Cellometer. 2x106 cells were plated into a 96-well plate and stained for extracellular markers CD4—Pacific Blue (BD Biosciences, clone RM4-5), CD8—Pacific Orange (Invitrogen, clone MCD0830), CD3—APCCy7 (BioLegend, clone 17A2), CD44—PerCP (BioLegend, IM7), CD62L—APC (eBioscience, clone MEL-14), CD43—FITC (BioLegend, clone 1B11), and CD43—PE (BD Pharmingen, S7). TruCount Beads from BD Pharmingen were prepared according to the manufacturer’s instructions and used to determine absolute cell counts.
+ Open protocol
+ Expand
8

Cytokine Analysis of Splenic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cytokine analysis, 2 x 106 splenic cells were plated into a 96-well plate. Cells were suspended in RMPI 1640 culture medium and incubated for four hours utilizing phorbol 12-myristate 13-acetate (30ng/mL) and ionomycin (400ng/mL) with 10μg/mL of Brefeldin A at 37°C. After stimulation, cells were then stained for the following intracellular and extracellular markers CD4—Pacific Blue (BD Biosciences, clone RM4-5), CD8—Pacific Orange (Invitrogen, clone MCD0830), CD25—FITC (BioLegend, clone PC61), CD3—Alexa 700 (BD Biosciences, 500A2), FOXP3—APC (eBioscience, FJK-16S), IL-2—FITC (BD Pharmingen, clone JES6-5H4), IL-4—PE (BioLegend, clone 11B11), CCR4—PE Cy7 (BioLegend, clone 2G12), CXCR3—APC (BioLegend, clone CXCR3-173), and IL-17A—PE (eBioscience, clone eBio17B7). Samples were run on an LSR II flow cytometer (BD Biosciences) and subsequent data was analyzed with FlowJo 10.0.8rl software (Tree Star, San Carlos, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!